230 related articles for article (PubMed ID: 24236200)
1. The role of metabotropic glutamate receptor 5 on the stromal cell-derived factor-1/CXCR4 system in oral cancer.
Kuribayashi N; Uchida D; Kinouchi M; Takamaru N; Tamatani T; Nagai H; Miyamoto Y
PLoS One; 2013; 8(11):e80773. PubMed ID: 24236200
[TBL] [Abstract][Full Text] [Related]
2. Involvement of an autocrine stromal cell derived factor-1/CXCR4 system on the distant metastasis of human oral squamous cell carcinoma.
Uchida D; Onoue T; Tomizuka Y; Begum NM; Miwa Y; Yoshida H; Sato M
Mol Cancer Res; 2007 Jul; 5(7):685-94. PubMed ID: 17634424
[TBL] [Abstract][Full Text] [Related]
3. Involvement of miR-518c-5p to growth and metastasis in oral cancer.
Kinouchi M; Uchida D; Kuribayashi N; Tamatani T; Nagai H; Miyamoto Y
PLoS One; 2014; 9(12):e115936. PubMed ID: 25536052
[TBL] [Abstract][Full Text] [Related]
4. Neuroprotective activity of the mGluR5 antagonists MPEP and MTEP against acute excitotoxicity differs and does not reflect actions at mGluR5 receptors.
Lea PM; Movsesyan VA; Faden AI
Br J Pharmacol; 2005 Jun; 145(4):527-34. PubMed ID: 15821750
[TBL] [Abstract][Full Text] [Related]
5. Possible role of stromal-cell-derived factor-1/CXCR4 signaling on lymph node metastasis of oral squamous cell carcinoma.
Uchida D; Begum NM; Almofti A; Nakashiro K; Kawamata H; Tateishi Y; Hamakawa H; Yoshida H; Sato M
Exp Cell Res; 2003 Nov; 290(2):289-302. PubMed ID: 14567988
[TBL] [Abstract][Full Text] [Related]
6. AMD3100 inhibits epithelial-mesenchymal transition, cell invasion, and metastasis in the liver and the lung through blocking the SDF-1α/CXCR4 signaling pathway in prostate cancer.
Zhu WB; Zhao ZF; Zhou X
J Cell Physiol; 2019 Jul; 234(7):11746-11759. PubMed ID: 30537000
[TBL] [Abstract][Full Text] [Related]
7. mGluR5 antagonist-induced psychoactive properties: MTEP drug discrimination, a pharmacologically selective non-NMDA effect with apparent lack of reinforcing properties.
Swedberg MD; Ellgren M; Raboisson P
J Pharmacol Exp Ther; 2014 Apr; 349(1):155-64. PubMed ID: 24472725
[TBL] [Abstract][Full Text] [Related]
8. Blockade of CXCR4 in oral squamous cell carcinoma inhibits lymph node metastases.
Uchida D; Onoue T; Kuribayashi N; Tomizuka Y; Tamatani T; Nagai H; Miyamoto Y
Eur J Cancer; 2011 Feb; 47(3):452-9. PubMed ID: 20965717
[TBL] [Abstract][Full Text] [Related]
9. The antinociceptive and anxiolytic-like effects of the metabotropic glutamate receptor 5 (mGluR5) antagonists, MPEP and MTEP, and the mGluR1 antagonist, LY456236, in rodents: a comparison of efficacy and side-effect profiles.
Varty GB; Grilli M; Forlani A; Fredduzzi S; Grzelak ME; Guthrie DH; Hodgson RA; Lu SX; Nicolussi E; Pond AJ; Parker EM; Hunter JC; Higgins GA; Reggiani A; Bertorelli R
Psychopharmacology (Berl); 2005 Apr; 179(1):207-17. PubMed ID: 15682298
[TBL] [Abstract][Full Text] [Related]
10. Blockade of metabotropic glutamate receptor 5 attenuates axonal degeneration in 6-hydroxydopamine-induced model of Parkinson's disease.
Zhang JN; Huang YL; Yang HM; Wang Y; Gu L; Zhang H
Mol Cell Neurosci; 2021 Jan; 110():103572. PubMed ID: 33248235
[TBL] [Abstract][Full Text] [Related]
11. IL-24 inhibits lung cancer cell migration and invasion by disrupting the SDF-1/CXCR4 signaling axis.
Panneerselvam J; Jin J; Shanker M; Lauderdale J; Bates J; Wang Q; Zhao YD; Archibald SJ; Hubin TJ; Ramesh R
PLoS One; 2015; 10(3):e0122439. PubMed ID: 25775124
[TBL] [Abstract][Full Text] [Related]
12. Activation of type 5 metabotropic glutamate receptor promotes the proliferation of rat retinal progenitor cell via activation of the PI-3-K and MAPK signaling pathways.
Zhang Z; Hu F; Liu Y; Ma B; Chen X; Zhu K; Shi Y; Wei T; Xing Y; Gao Y; Lu H; Liu Y; Kang Q
Neuroscience; 2016 May; 322():138-51. PubMed ID: 26902516
[TBL] [Abstract][Full Text] [Related]
13. A novel mGluR5 antagonist, MFZ 10-7, inhibits cocaine-taking and cocaine-seeking behavior in rats.
Keck TM; Zou MF; Bi GH; Zhang HY; Wang XF; Yang HJ; Srivastava R; Gardner EL; Xi ZX; Newman AH
Addict Biol; 2014 Mar; 19(2):195-209. PubMed ID: 24001208
[TBL] [Abstract][Full Text] [Related]
14. CXCR4/SDF-1 axis is involved in lymph node metastasis of gastric carcinoma.
Zhao BC; Wang ZJ; Mao WZ; Ma HC; Han JG; Zhao B; Xu HM
World J Gastroenterol; 2011 May; 17(19):2389-96. PubMed ID: 21633638
[TBL] [Abstract][Full Text] [Related]
15. [Effect of chemokine stromal cell derived factor-1 and its receptor CXCR4 on the peritoneal carcinometastasis of gastric cancer].
Ding YL; Zhang JL; Tang SF; Fu QY; Li ZT
Zhonghua Yi Xue Za Zhi; 2008 Jan; 88(3):202-5. PubMed ID: 18361822
[TBL] [Abstract][Full Text] [Related]
16. Metabotropic glutamate receptor subtype 5 antagonists MPEP and MTEP.
Lea PM; Faden AI
CNS Drug Rev; 2006; 12(2):149-66. PubMed ID: 16958988
[TBL] [Abstract][Full Text] [Related]
17. Vesnarinone downregulates CXCR4 expression via upregulation of Krüppel-like factor 2 in oral cancer cells.
Uchida D; Onoue T; Begum NM; Kuribayashi N; Tomizuka Y; Tamatani T; Nagai H; Miyamoto Y
Mol Cancer; 2009 Aug; 8():62. PubMed ID: 19671192
[TBL] [Abstract][Full Text] [Related]
18. Cancer-associated fibroblasts promote the progression of endometrial cancer via the SDF-1/CXCR4 axis.
Teng F; Tian WY; Wang YM; Zhang YF; Guo F; Zhao J; Gao C; Xue FX
J Hematol Oncol; 2016 Feb; 9():8. PubMed ID: 26851944
[TBL] [Abstract][Full Text] [Related]
19. [Effect of stromal cell-derived factor-1 and its receptor CXCR4 on liver metastasis of human colon cancer].
Ding YL; Fu QY; Tang SF; Zhang JL; Li ZY; Li ZT
Zhonghua Wai Ke Za Zhi; 2009 Feb; 47(3):210-3. PubMed ID: 19563077
[TBL] [Abstract][Full Text] [Related]
20. Stromal cell-derived factor-1/CXCR4 enhanced motility of human osteosarcoma cells involves MEK1/2, ERK and NF-kappaB-dependent pathways.
Huang CY; Lee CY; Chen MY; Yang WH; Chen YH; Chang CH; Hsu HC; Fong YC; Tang CH
J Cell Physiol; 2009 Oct; 221(1):204-12. PubMed ID: 19496172
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
